Novo Nordisk
NVO
NVO
658 hedge funds and large institutions have $9.68B invested in Novo Nordisk in 2020 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 197 increasing their positions, 240 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
0.45% less ownership
Funds ownership: 15.83% → 15.38% (-0.45%)
18% less repeat investments, than reductions
Existing positions increased: 197 | Existing positions reduced: 240
25% less funds holding in top 10
Funds holding in top 10: 16 → 12 (-4)
Holders
658
Holding in Top 10
12
Calls
$55.8M
Puts
$25.1M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$14.1M | |
| 3 | +$14M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.8M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$12M |
Top Sellers
| 1 | -$126M | |
| 2 | -$40.9M | |
| 3 | -$26.2M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$25.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$23.8M |